The trauma created by the pandemic has understandably meant we’re looking for rapid solutions to complex problems.
Rich Western countries have bought up most of the supply of vaccines in a headlong rush to protect their own populations.
But isn’t the key to universal public health access to medicine for all?
Host Ross Ashcroft is joined by public health activist Achal Prabhala and Andrea Taylor from the Global Health Innovation Center to ask if this blinkered approach will end up costing everyone much more.
